<DOC>
	<DOCNO>NCT00934050</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety tolerability ELND005 beyond 18 month treatment original randomize blinded clinical trail ELND005-AD201 .</brief_summary>
	<brief_title>ELND005 Long-Term Follow-up Study Subjects With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>This study open subject complete week 78 visit Study ELND005AD201 take assign dose study drug medication . Subject new medical contraindication continue participation study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>